Tirofiban administration attenuates platelet and platelet-neutrophil conjugation but not neutrophil degranulation during in vitro VAD circulation.
King, B O
Tirofiban administration attenuates platelet and platelet-neutrophil conjugation but not neutrophil degranulation during in vitro VAD circulation. [electronic resource] - ASAIO journal (American Society for Artificial Internal Organs : 1992) - 282-7 p. digital
Publication Type: Journal Article
1058-2916
10.1097/00002480-200105000-00025 doi
Blood Platelets--drug effects
Cell Degranulation--drug effects
Complement Activation
Heart-Assist Devices
Humans
In Vitro Techniques
Leukocyte Elastase--metabolism
Leukotriene C4--metabolism
Neutrophils--drug effects
Platelet Aggregation Inhibitors--pharmacology
Platelet Factor 4--metabolism
Platelet Glycoprotein GPIIb-IIIa Complex--metabolism
Tirofiban
Tyrosine--analogs & derivatives
Tirofiban administration attenuates platelet and platelet-neutrophil conjugation but not neutrophil degranulation during in vitro VAD circulation. [electronic resource] - ASAIO journal (American Society for Artificial Internal Organs : 1992) - 282-7 p. digital
Publication Type: Journal Article
1058-2916
10.1097/00002480-200105000-00025 doi
Blood Platelets--drug effects
Cell Degranulation--drug effects
Complement Activation
Heart-Assist Devices
Humans
In Vitro Techniques
Leukocyte Elastase--metabolism
Leukotriene C4--metabolism
Neutrophils--drug effects
Platelet Aggregation Inhibitors--pharmacology
Platelet Factor 4--metabolism
Platelet Glycoprotein GPIIb-IIIa Complex--metabolism
Tirofiban
Tyrosine--analogs & derivatives